Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Phase I Safety Trial: As noted, a Phase I trial (the first step in testing a drug in humans, usually focused on safety and pharmacokinetics) was registered in 2015, aiming to give BPC-157 to healthy volunteers
This ingredient is generally well-tolerated, non-irritating, and non-sensitizing for the majority of people
Most patients reach a therapeutic maintenance dose (1.0-2.0 mg) within eight to twelve weeks
If homocysteine levels are found to be abnormally high, treatment is simple
Using the Calculator: Enter the peptide amount (1 mg for IGF1 LR3 1MG) Enter the desired dose in micrograms (mcg) The calculator will display the volume to inject Example Calculation: Peptide amount: 1 mg (1000 mcg) Mixing volume: 2 mL Level: 500 mcg/mL Desired dose: 50 mcg Volume to inject: 0.1 mL (10 units on insulin syringe) Research Dosage Protocols IGF1 LR3 dosage in research uses varies based on the specific research objectives, subject characteristics, and protocol design
The American College of Sports Medicine (ACSM) recommends a sodium intake of 300 to 600 milligrams per hour for endurance athletes who exercise for over two hours or are considered heavy sweaters, losing more than 1.2 liters per hour
US$ 22.97
US$ 23.91
US$ 21.54
